• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肽段的HLA II类分子与自身免疫性疾病易感性的分析

Peptide-based molecular analyses of HLA class II-associated susceptibility to autoimmune diseases.

作者信息

Nishimura Y, Oiso M, Fujisao S, Kanai T, Kira J, Chen Y Z, Matsushita S

机构信息

Department of Neuroscience and Immunology, Kumamoto University Graduate School of Medical Sciences, Japan.

出版信息

Int Rev Immunol. 1998;17(5-6):229-62. doi: 10.3109/08830189809054404.

DOI:10.3109/08830189809054404
PMID:10036633
Abstract

Recent advances in knowledge of crystal structures of MHC class II molecules has advanced understanding of the molecular basis for interactions between peptides and HLA class II molecules. Polymorphism of HLA class II molecules influences structures of peptides bound to HLA class II molecules. To better understand mechanisms related to particular HLA class II alleles and autoimmune diseases, it is important to identify self-peptides presented by disease-susceptible HLA class II molecules and triggering disease-causative autoreactive T cells. Autoimmune diseases occur in Caucasians, Blacks and Asians, albeit with a different incidence. In some autoimmune diseases, disease-susceptible HLA class II alleles are closely related but different, and clinical manifestations of diseases differ among ethnic groups. These phenomena strongly suggest that difference in autoimmune self-peptide(s) in the context of disease-susceptible HLA class II molecules may explain the different clinical manifestations of diseases. Therefore, a comparison among disease-susceptible HLA class II alleles, autoimmune self-peptides and clinical manifestations of autoimmune diseases in different ethnic groups would be instructive. We directed efforts to determining: (1) HLA-class II alleles specific to Asian populations and which are associated with susceptibility to autoimmune diseases, (2) binding-peptide motifs for these HLA class II molecules, and (3) self-peptides presented by susceptible HLA class II molecules to stimulate autoreactive T cells related to the development of autoimmune diseases in Asians. In this review, our related recent investigations are described and the uniqueness of HLA class II-associated autoimmune diseases in Asians is given emphasis.

摘要

近年来,对MHC II类分子晶体结构的认识取得了进展,这增进了我们对肽与HLA II类分子相互作用分子基础的理解。HLA II类分子的多态性会影响与HLA II类分子结合的肽的结构。为了更好地理解与特定HLA II类等位基因和自身免疫性疾病相关的机制,识别由疾病易感性HLA II类分子呈递并触发致病自身反应性T细胞的自身肽非常重要。自身免疫性疾病在白种人、黑人和亚洲人中均有发生,尽管发病率有所不同。在一些自身免疫性疾病中,疾病易感性HLA II类等位基因密切相关但又有所不同,且不同种族的疾病临床表现也存在差异。这些现象强烈表明,在疾病易感性HLA II类分子背景下自身免疫性自身肽的差异可能解释了疾病不同的临床表现。因此,比较不同种族中疾病易感性HLA II类等位基因、自身免疫性自身肽和自身免疫性疾病的临床表现将具有指导意义。我们致力于确定:(1)亚洲人群特有的、与自身免疫性疾病易感性相关的HLA II类等位基因;(2)这些HLA II类分子的结合肽基序;(3)易感性HLA II类分子呈递的自身肽,以刺激与亚洲人自身免疫性疾病发展相关的自身反应性T细胞。在这篇综述中,我们描述了近期的相关研究,并强调了亚洲人HLA II类相关自身免疫性疾病的独特性。

相似文献

1
Peptide-based molecular analyses of HLA class II-associated susceptibility to autoimmune diseases.基于肽段的HLA II类分子与自身免疫性疾病易感性的分析
Int Rev Immunol. 1998;17(5-6):229-62. doi: 10.3109/08830189809054404.
2
[Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases].[对自身免疫性疾病敏感的HLA II类分子的结合肽基序]
Nihon Rinsho. 1997 Jun;55(6):1384-96.
3
Molecular analyses of HLA class II-associated susceptibility to subtypes of autoimmune diseases unique to Asians.与亚洲人特有的自身免疫性疾病亚型相关的HLA II类分子易感性分析。
Int J Cardiol. 1998 Oct 1;66 Suppl 1:S93-104; discussion S105. doi: 10.1016/s0167-5273(98)00156-9.
4
Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population.对日本人群中与 HLA Ⅱ类相关的自身免疫性疾病易感性的分子和细胞分析。
Mod Rheumatol. 2001 Jun;11(2):103-12. doi: 10.3109/s101650170020.
5
Molecular aspects of HLA class II and some autoimmune diseases.人类白细胞抗原(HLA)II类分子与某些自身免疫性疾病的分子机制
Eur J Immunogenet. 1993 Jun;20(3):153-64. doi: 10.1111/j.1744-313x.1993.tb00106.x.
6
HLA class II transgenic mice as models of human diseases.HLA II类转基因小鼠作为人类疾病模型。
Immunol Rev. 1999 Jun;169:67-79. doi: 10.1111/j.1600-065x.1999.tb01307.x.
7
Molecular probing of disease susceptibility genes in myasthenia gravis patients: an analysis of T-cell receptor and HLA class II genes using restriction fragment length polymorphism.重症肌无力患者疾病易感性基因的分子探测:利用限制性片段长度多态性分析T细胞受体和HLA II类基因
Ann N Y Acad Sci. 1987;505:388-97. doi: 10.1111/j.1749-6632.1987.tb51309.x.
8
Mutagenesis and expression of putative class II susceptibility genes: a "reverse immunogenetics" approach to analysis of HLA and disease.假定的II类易感性基因的诱变与表达:一种分析HLA与疾病的“反向免疫遗传学”方法
Autoimmunity. 1990;7(2-3):189-99. doi: 10.3109/08916939008993391.
9
A molecular basis for MHC class II--associated autoimmunity.MHC II类相关自身免疫的分子基础。
Science. 1988 May 20;240(4855):1003-9. doi: 10.1126/science.3368786.
10
Immuno-suppressive peptides for a human T cell clone autoreactive to a unique acetylcholine receptor alpha subunit peptide presented by the disease-susceptible HLA-DQ6 in infant-onset myasthenia gravis.
Hum Immunol. 1997 Aug-Sep;56(1-2):28-38. doi: 10.1016/s0198-8859(97)00142-0.

引用本文的文献

1
Clinical and HLA genotype analysis of immune checkpoint inhibitor-associated diabetes mellitus: a single-center case series from China.免疫检查点抑制剂相关糖尿病的临床和 HLA 基因型分析:来自中国的单中心病例系列。
Front Immunol. 2023 Jun 9;14:1164120. doi: 10.3389/fimmu.2023.1164120. eCollection 2023.
2
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis.在何处、如何以及何时:1型糖尿病发病机制中的翻译后修饰定位
Curr Diab Rep. 2016 Jul;16(7):63. doi: 10.1007/s11892-016-0752-4.
3
Glutamic acid decarboxylase 65 and islet cell antigen 512/IA-2 autoantibodies in relation to human leukocyte antigen class II DR and DQ alleles and haplotypes in type 1 diabetes mellitus.
1型糖尿病中谷氨酸脱羧酶65和胰岛细胞抗原512/IA-2自身抗体与人类白细胞抗原II类DR和DQ等位基因及单倍型的关系
Clin Vaccine Immunol. 2011 Jun;18(6):990-3. doi: 10.1128/CVI.00073-11. Epub 2011 Apr 13.